社会任职
中华医学会血液学分会第十一届委员会造血干细胞应用学组组员；
中华医学会血液学分会第十届委员会造血干细胞应用学组组员；
曾任黑龙江省医师协会血液学分会副主任委员；
黑龙江省医院协会血液病专业委员会副主任委员。
Department:
Hematology
Professional:
Chief Physician, M.D., Professor
Position:
和祐医院血液内科主任
With over 30 years of medical experience
Introduction:
Dr. Li Limin has dedicated over 30 years to the diagnosis and treatment of hematological diseases. She specializes in managing both benign and malignant conditions such as leukemia and lymphoma, with particular expertise in relapsed and refractory leukemia, hematopoietic stem cell transplantation, and immunotherapy. She has performed more than 500 hematopoietic stem cell transplants, with relapsed and refractory cases accounting for two-thirds of the total; over 90% of these were haploidentical transplants, achieving a 100% engraftment rate. The first patient to undergo a haploidentical transplant has been in good health for over 20 years, and the five-year survival rate for patients transplanted during remission reaches 90.2%. She was a pioneer in CAR-T therapy, having treated nearly 70 patients with relapsed or refractory acute lymphoblastic leukemia, achieving a complete remission rate of 92.3%. She excels at developing personalized treatment plans by combining traditional therapies with targeted immunotherapy.
Area Of Expertise:
Dr. Li Limin has dedicated over 30 years to the field of hematology and has achieved profound expertise in the diagnosis and treatment of both benign and malignant hematological disorders, including leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes, aplastic anemia, and thrombocytopenia. She is particularly skilled in managing relapsed and refractory leukemia and has extensive experience in hematopoietic stem cell transplantation and novel immunotherapies.
Academic Achievements:
参编“十二五”、“十三五”规划教材；担任《中华细胞与干细胞杂志》通讯编委；主持省级基金课题，国家自然科学基金等8项；2011年获省政府科学技术奖一等奖，2016年获省卫生厅医疗新技术奖一等奖；发表论文60余篇，其中SCI收录21篇；参与撰写国内血液病领域权威专家共识及指南12部。
